Knee Replacement News and Research

RSS

Colorado PERA now offers new hip and knee replacement benefit option for retirees in pre-Medicare program

Taking a critical step in eliminating confusion around health care costs, as well as addressing a significant need among today's retired workers, Colorado Public Employees' Retirement Association announced it will now offer its retirees in the pre-Medicare program a new hip and knee replacement benefit option called PERACare Select.

29 Aug 2015

Programme to tackle superbugs announced by charity

Antibiotic Research UK announced at its Annual General meeting its first research programme to tackle antibiotic resistant bacteria (superbugs).

20 Aug 2015

CyMedica Orthopedics secures CE Mark for QB1 Muscle Activation System

CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FDA 510(k) clearance in April 2015, and has since enjoyed a tremendous reception from orthopedic surgeons and knee patients across the United States.

11 Aug 2015

Mercy Medical Center named third best hospital in Maryland

U.S. News & World Report has released its annual "Best Hospital" rankings. This 26th annual edition includes information on nearly 5,000 hospitals nationwide. U.S. News & World Report named Mercy Medical Center in Baltimore as the third best hospital in Maryland, behind only the academic medical centers at Johns Hopkins and the University of Maryland. Mercy also retained its status from last year as the state's top-ranked community hospital.

23 Jul 2015

Study compares outcomes for in-person and in-home telerehabilitation following TKR surgery

Patients who received rehabilitation instructions via video teleconference, or "telerehabilitation," following total knee replacement (TKR) surgery had comparable outcomes to patients who received in-person physical therapy, according to a study appearing in the July 15 issue of The Journal of Bone & Joint Surgery.

16 Jul 2015

Consumers get access to nationwide ratings of individual surgeons based on patient outcomes

Preventable medical errors of various kinds kill at least 200,000 Americans each year, making this the third leading cause of death in the United States, six times as many deaths as from auto accidents. One way to reduce such errors is for consumers to choose the best surgeons. For the first time ever, consumers across the U.S. today have access to ratings of individual surgeons based on outcomes—how often their patients die in hospital or within 90 days of hospital discharge, have serious complications in hospital, or need to be readmitted to a hospital within 90 days of discharge.

14 Jul 2015

Anika Therapeutics announces positive results from CINGAL phase 3 trial for knee osteoarthritis

Anika Therapeutics, Inc.,, a leader in products for tissue protection, healing, and repair based on hyaluronic acid technology, today reported positive results from the CINGAL 13-02 study evaluating the safety of a repeat injection of Cingal for symptomatic relief of osteoarthritis of the knee.

10 Jul 2015

ProfNet network experts available to discuss timely issues in your coverage area

Below are experts from the ProfNet network that are available to discuss timely issues in your coverage area. You can also submit a query to the hundreds of thousands of experts in our network – it's easy and free!

27 Jun 2015

Readmission to same hospital for post-surgical complications improves survival

Patients rehospitalized with complications after major surgery are 26% more likely to survive if they return to the hospital where they had their operation compared to those readmitted to a different hospital, according to a national study involving over 9 million Medicare patients in the USA, published in The Lancet.

22 Jun 2015

Heparin market in Europe estimated to reach USD 3,148.0 million by 2022

According to a new market report published by Transparency Market Research Heparin Market - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2022" the Heparin Market Europe was valued at USD 2,004.5 million in 2013 and is estimated to reach USD 3,148.0 million by 2022 growing with a CAGR of 5.2% from 2014 to 2022.

17 Jun 2015

Simple pre-surgical intervention can reduce S aureus surgical site infections

Implementation of a pre-surgical intervention that included screening for the bacteria Staphylococcus aureus, treating patients who were positive for this bacteria, and the administration of antibiotics based on these culture results was associated with a modest reduction in S aureus surgical site infections, according to a study in the June 2 issue of JAMA.

3 Jun 2015

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the initiation of CALLISTO, a new comprehensive clinical research program for their novel oral anticoagulant, rivaroxaban, in patients with active cancer. The studies are evaluating the medicine for the prevention and treatment of life-threatening blood clots in patients with a wide range of cancer types.

28 May 2015

Mayo Clinic hospitals earn top-tier High Performing distinction in U.S. News & World Report ratings

Mayo Clinic Hospitals in Rochester, Minn, and Phoenix earned the top-tier High Performing distinction in all five common care categories in the latest ratings by U.S. News & World Report.

21 May 2015

Touch surgery awarded Rising Star award at Founders Forum

The accolade of Smart Nation Rising Star comes on the heels a public announcement that the Touch Surgery app is now used by over 200,000 surgeons in every country on earth...

12 May 2015

Kaiser Permanente, Intermountain Healthcare to participate in U.S. News Hospital Outcome Data Disclosure Program

U.S. News & World Report, publisher of Best Hospitals and Best Children's Hospitals, today announced that Kaiser Permanente and Intermountain Healthcare will participate in the U.S. News Hospital Outcome Data Disclosure Program, a new data-collection initiative designed to evaluate hospitals more completely and give patients better information about the hospitals in their communities.

7 May 2015

UI orthopedics researchers working on injectable, bioactive gel that can repair cartilage damage

Knee injuries are the bane of athletes everywhere, from professionals and college stars to weekend warriors. Current surgical options for repairing damaged cartilage caused by knee injuries are costly, can have complications, and often are not very effective in the long run. Even after surgery, cartilage degeneration can progress leading to painful arthritis.

29 Apr 2015

FDA announces voluntary recall of Zimmer knee product

MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that the FDA announced a Class II recall for Zimmer's Persona Trabecular Metal Tibial Plate knee implant. The recall affects all lots and sizes of the knee implant, affecting all 11,658 devices that were recalled, according to the FDA's website.

23 Apr 2015

Blue Cross Blue Shield of Michigan, UMHS collaborate to improve quality of care for Michiganians

Blue Cross Blue Shield of Michigan and the University of Michigan Health System will collaborate with emergency physicians at participating hospitals across the state to develop best practices to improve the experience and outcomes of patients receiving care in emergency departments.

21 Apr 2015

Moirai Orthopaedics receives FDA approval for IDE application to initiate clinical study of PIR System

Moirai Orthopaedics, L.L.C., an orthopaedic implant development company based in Metairie, Louisiana, is pleased to announce it has received approval from the US Food and Drug Administration for its Investigational Device Exemption (IDE) application to initiate clinical study of the company's Pyrocarbon Implant Replacement (PIR) System.

16 Apr 2015

Jersey Shore achieves Joint Commission certification for Hip and Knee Joint Replacement Program

Jersey Shore has earned The Joint Commission's Gold Seal of Approval for its Hip and Knee Joint Replacement Program by demonstrating compliance with The Joint Commission's national standards for health care quality and safety in disease-specific care. The certification award recognizes the hospital's dedication to continuous compliance with The Joint Commission's rigorous standards.

8 Apr 2015